Vericel Denmark ApS: Financial statements 2024
CVR: 19740986
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Vericel Denmark ApS (CVR 19740986) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -109,464 and a net result of DKK -109,464 compared with DKK -115,548 the year before. Equity in the 2024 report amounted to DKK 6,369,816. The solvency ratio was 99.6%.
- Gross Profit
- DKK -109,464
- Profit/Loss
- DKK -109,464
- Equity
- DKK 6,369,816
- Total Assets
- DKK 6,396,645
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -109 t. | -109 t. | 6.4 mio. | 0 |
| 2023 | - | -116 t. | -116 t. | 6.5 mio. | 0 |
| 2022 | - | -122 t. | -122 t. | 6.6 mio. | 0 |
| 2021 | - | -122 t. | -122 t. | 6.7 mio. | 0 |
| 2020 | - | -83 t. | -83 t. | 6.8 mio. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Vericel Denmark ApS has published its annual report for 2023. Gross profit came to DKK -115,548, and the net result was DKK -115,548.
About Vericel Denmark ApS
Vericel Denmark ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 1996. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named AASTROM BIOSCIENCES DK ApS and GENZYME BIOSURGERY ApS. The management consists of Joseph Anthony Mara Jr. The company is owned by Vericel Corporation. The company has 0 employees (2015). In 2025, the company reported a gross profit of DKK -128,481 and a net result of DKK -128,481 compared with DKK -109,464 the year before. Equity in the 2025 report amounted to DKK 6,241,335.